Incyte
INCY
#1186
Rank
$18.59 B
Marketcap
$94.71
Share price
-0.47%
Change (1 day)
31.34%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of September 2025 : $6.33 Billion USD

According to Incyte's latest financial reports the company's total assets are $6.33 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$5.44 B-19.73%
2023-12-31$6.78 B16.11%
2022-12-31$5.84 B18.4%
2021-12-31$4.93 B38.54%
2020-12-31$3.56 B3.92%
2019-12-31$3.42 B29.52%
2018-12-31$2.64 B14.9%
2017-12-31$2.30 B40.52%
2016-12-31$1.63 B62.65%
2015-12-31$1.00 B26.49%
2014-12-31$0.79 B26.51%
2013-12-31$0.62 B90.54%
2012-12-31$0.33 B0.44%
2011-12-31$0.32 B-32.81%
2010-12-31$0.48 B-31.28%
2009-12-31$0.71 B206.55%
2008-12-31$0.23 B-15.71%
2007-12-31$0.27 B-22.03%
2006-12-31$0.35 B-5.48%
2005-12-31$0.37 B-27.63%
2004-12-31$0.51 B36.19%
2003-12-31$0.37 B-31.26%
2002-12-31$0.55 B-21.74%
2001-12-31$0.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
$90.14 B 1,323.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$1.47 B-76.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$114.93 B 1,715.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 3,197.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.56 B-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.48 B-92.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$107.28 B 1,594.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
$0.10 B-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$0.11 B-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA